BD² aims to close a fundamental gap in science’s understanding of the genetic mechanisms of bipolar disorder.
Compared to other mental health disorders such as schizophrenia or major depressive disorder, bipolar disorder has far less available genetic data, which has hindered understanding and treatment.
The BD² Genetics Platform will collect and genotype a large number of samples from individuals with diverse backgrounds who experience bipolar disorder. We will also sequence samples from individuals enrolled in the BD² Integrated Network.
We are currently reviewing proposals for grant awards in spring 2023. Sign up for Thrive Updates for the latest news and information.
Our commitment to open science invites researchers to access and expand upon new findings, accelerating the process of discovery across the entire bipolar disorder research landscape.